Use of the sequence encoding of the carboxyl-terminal domain...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/08 (2006.01) C07K 14/33 (2006.01)

Patent

CA 2701521

The invention relates to the use of the sequence encoding the carboxyl- terminal end domain of the heavy chain of the tetanus toxin as a drug, preferably in the treatment of amyotrophic lateral sclerosis (ALS), as well as the polypeptide encoded by said sequence for the treatment of the aforementioned disease.

La presente invención se refiere al uso de la secuencia codificante del domino del extremo carboxilo terminal de la cadena pesada de la toxina tetánica como medicamento, preferentemente en el tratamiento de la Esclerosis Lateral Amiotrófica (ELA), así como el polipéptido codificado por dicha secuencia para el tratamiento de la mencionada enfermedad.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of the sequence encoding of the carboxyl-terminal domain... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of the sequence encoding of the carboxyl-terminal domain..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of the sequence encoding of the carboxyl-terminal domain... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1698515

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.